Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-19

Clinical Trial Update: Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prednisolone in a modified conjunctival allergen challenge model for chronic allergic conjunctivitis; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prednisolone (Prednisolone)

Snippet

Sponsor: ORA, Inc. | Conditions: Chronic Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2019-06-19